Recombinant IL17A (Secukinumab Biosimilar) antibody

Catalog No. ABIN7487945

This Mammalian Cells Monoclonal antibody specifically detects IL17A (Secukinumab Biosimilar) in ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant IL17A (Secukinumab Biosimilar) antibody (ABIN7487945)

Target: IL17A (Secukinumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IL17A (Secukinumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-IL17A (Secukinumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Secukinumab Biosimilar - Anti-IL17A mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for IL17A (Secukinumab Biosimilar)

Target: IL17A (Secukinumab Biosimilar)

Target Type: Biosimilar

Background: AIN457
Secukinumab is a fully human monoclonal immunoglobulin G1κ antibody targeting human interleukin-17A( IL-17A ). IL-17A is a naturally occurring cytokine that is involved in normal inflammatory and immune responses.